PseudoMeigs syndrome. Associated with metastatic cancer of ovary
Ryan, R.J.
New York State Journal of Medicine 72(6): 727-730
1972
ISSN/ISBN: 0028-7628 PMID: 4501545 Document Number: 56561
Document emailed within 1 workday
Related Documents
Liu, L.Y. 1989: Metastatic cancer in the ovary--report of 57 cases Zhonghua Zhong Liu Za Zhi 11(6): 464-467Webb, M.J.; Decker, D.G.; Mussey, E. 1975: Cancer metastatic to the ovary: factors influencing survival Obstetrics and Gynecology 45(4): 391-396
Presl, J. 1984: The direct effect of insulin on the ovary and the pathogenesis of the polycystic ovary syndrome Ceskoslovenska Gynekologie 49(2): 124-125
Cerea, G.; Vaghi, M.; Ardizzoia, A.; Villa, S.; Bucovec, R.; Mengo, S.; Gardani, G.; Tancini, G.; Lissoni, P. 2003: Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations Anticancer Research 23(2c): 1951-1954
Komolafe, M.A.; Sunmonu, T.A.; Oke, O. 2009: Stroke-like syndrome in a middle aged Nigerian woman with metastatic brain cancer West African Journal of Medicine 28(4): 266-269
Bacalbasa, N.; Balescu, I.; Balalau, C.; Ionescu, O.; Stoica, C. 2018: Normal Size Ovary Carcinoma Syndrome with Inguinal Ovarian Cancer Lymph Node Metastases - A Case Report and Literature Review In Vivo 32(2): 385-389
Okagawa, Y.; Sato, Y.; Onuma, H.; Osuga, T.; Hayashi, T.; Sato, T.; Miyanishi, K.; Kobune, M.; Takimoto, R.; Kato, J. 2015: A Case of Fanconi Syndrome Induced by Zoledronic Acid in a Metastatic Colorectal Cancer Patient Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(7): 867-870
Clark, A.K.; Sarcon, A.K.; Fung, M.A.; Konia, T.; Laurin, E.G.; Sivamani, R.K. 2017: Malignancy-associated Sweet syndrome: acute febrile neutrophilic dermatosis associated with recurrence of metastatic cervical cancer Dermatology Online Journal 23(4)
Porter, G.F.; Braatvedt, G. 1994: Superior vena cava syndrome due to localised metastatic of breast cancer treated with a peripheral streptokinase infusion New Zealand Medical Journal 107(987): 404
Oztop, I.; Demirkan, B.; Yaren, A.; Tarhan, O.; Sengul, B.; Ulukus, C.; Akin, D.; Sen, M.; Yilmaz, U.; Alakavuklar, M. 2004: Rapid tumor lysis syndrome in a patient with metastatic colon cancer as a complication of treatment with 5-fluorouracil/leucoverin and irinotecan Tumori 90(5): 514-516
Prakansamut, N.; Sirayapiwat, P.; Triratanachat, S. 2014: The percentages of endometrial hyperplasia and endometrial cancer among polycystic ovary syndrome (PCOS) patients presenting with abnormal menstrual pattern Journal of the Medical Association of Thailand 97(2): 159-164
Yang, J.-L.; Jackson, P.; Yu, Y.; Russell, P.J.; Markovic, B.; Crowe, P.J. 2002: Expression of the KAI1 metastasis suppressor gene in non-metastatic versus metastatic human colorectal cancer Anticancer Research 22(6a): 3337-3342
Costello, M.; Shrestha, B.; Eden, J.; Sjoblom, P.; Johnson, N. 2007: Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome Cochrane Database of Systematic Reviews 1: Cd005552
Murgić, J.; Prpić, M.; Kirac, I.; Camino-Varela, A.-M.; Bolanca, A.; Kusić, Z. 2012: Dermatomyositis as paraneoplastic syndrome of peritoneal and ovarian relapse after long-term complete remission in patient with metastatic bilateral breast cancer Collegium Antropologicum 36(1): 325-329
Matsui, T.; Sakamoto, N.; Doi, A.; Fujii, T.; Ohno, N.; Sahara, N.; Irie, S. 2018: Azacitidine for Therapy-Related Myelodysplastic Syndrome Following Oxaliplatin (L-OHP)Therapy for Metastatic Rectal Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(8): 1201-1203
Pantasri, T.; Vutyavanich, T.; Sreshthaputra, O.; Srisupundit, K.; Piromlertamorn, W. 2010: Metabolic syndrome and insulin resistance in Thai women with polycystic ovary syndrome Journal of the Medical Association of Thailand 93(4): 406-412
Kamrul-Hasan, A.B.; Aalpona, F.Z. 2019: Association of Vitamin D Status with Metabolic Syndrome and its Components in Polycystic Ovary Syndrome Mymensingh medical journal: MMJ 28(3): 547-552
Indhavivadhana, S.; Wongwananuruk, T.; Rattanachaiyanont, M.; Techatraisak, K.; Leerasiri, P.; Tanmahasamut, P.; Popijan, M. 2010: Prevalence of metabolic syndrome in reproductive-aged polycystic ovary syndrome Thai women Journal of the Medical Association of Thailand 93(6): 653-660
Cheung, L.P.; Ma, R.C.W.; Lam, P.M.; Lok, I.H.; Haines, C.J.; So, W.Y.; Tong, P.C.Y.; Cockram, C.S.; Chow, C.C.; Goggins, W.B. 2008: Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome Human Reproduction 23(6): 1431-1438
Barber, T.M.; McCarthy, M.I.; Franks, S.; Wass, J.A.H. 2007: Metabolic syndrome in polycystic ovary syndrome Endokrynologia Polska 58(1): 34-41